
Last updated: 2026-09-16 06:00:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Medline Inc. (MDLN) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $32.10, with a market capitalisation of $28.54B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $31.63 to $50.88. This page covers its latest market performance, valuation, price trends and company information.
$28.54B | |
$32.56 | |
$50.88 | |
$31.63 | |
$32.59 | |
6.58M | |
7.45M | |
-- | |
$50.88 | |
$31.63 | |
-- | |
-- |
Medline Inc. (MDLN) last closed at $32.59 as of 2026-09-15 23:31:00, unchanged from the previous close of $32.59.
During the latest regular trading session, MDLN traded between $31.63 and $50.88, with a volume of 6.58M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Medline Inc. (MDLN) moved from $36.59 to $32.10, representing a decline of 12.26% ($4.49).
The stock traded between $31.63 and $36.99 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 5.77 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.5%
MDLN is currently trading at $32.10, placing it 2.5% of the way from its 52-week low of $31.63 to its 52-week high of $50.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 45000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Medline Inc. (MDLN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.